These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 8595623)
1. Pharmacology of the high-affinity apamin receptor in rabbit heart. Schetz JA; Anderson PA Cardiovasc Res; 1995 Nov; 30(5):755-62. PubMed ID: 8595623 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2. Jäger H; Grissmer S Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028 [TBL] [Abstract][Full Text] [Related]
4. A novel scorpion toxin blocking small conductance Ca2+ activated K+ channel. Xu CQ; He LL; Brône B; Martin-Eauclaire MF; Van Kerkhove E; Zhou Z; Chi CW Toxicon; 2004 Jun; 43(8):961-71. PubMed ID: 15208029 [TBL] [Abstract][Full Text] [Related]
5. An apamin- and scyllatoxin-insensitive isoform of the human SK3 channel. Wittekindt OH; Visan V; Tomita H; Imtiaz F; Gargus JJ; Lehmann-Horn F; Grissmer S; Morris-Rosendahl DJ Mol Pharmacol; 2004 Mar; 65(3):788-801. PubMed ID: 14978258 [TBL] [Abstract][Full Text] [Related]
6. Small-conductance Ca(2+)-activated K(+) channels: Heterogeneous affinity in rat brain structures and cognitive modulation by specific blockers. Mpari B; Sreng L; Regaya I; Mourre C Eur J Pharmacol; 2008 Jul; 589(1-3):140-8. PubMed ID: 18561910 [TBL] [Abstract][Full Text] [Related]
7. Leiurotoxin I (scyllatoxin), a peptide ligand for Ca2(+)-activated K+ channels. Chemical synthesis, radiolabeling, and receptor characterization. Auguste P; Hugues M; Gravé B; Gesquière JC; Maes P; Tartar A; Romey G; Schweitz H; Lazdunski M J Biol Chem; 1990 Mar; 265(8):4753-9. PubMed ID: 2307683 [TBL] [Abstract][Full Text] [Related]
8. Partial apamin sensitivity of human small conductance Ca2+-activated K+ channels stably expressed in Chinese hamster ovary cells. Dale TJ; Cryan JE; Chen MX; Trezise DJ Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):470-7. PubMed ID: 12382077 [TBL] [Abstract][Full Text] [Related]
9. Apamin: a specific toxin to study a class of Ca2+-dependent K+ channels. Romey G; Hugues M; Schmid-Antomarchi H; Lazdunski M J Physiol (Paris); 1984; 79(4):259-64. PubMed ID: 6099412 [TBL] [Abstract][Full Text] [Related]
10. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker. Suh-Kim H; Wei X; Birnbaumer L Mol Pharmacol; 1996 Nov; 50(5):1330-7. PubMed ID: 8913365 [TBL] [Abstract][Full Text] [Related]
11. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine. Glossmann H; Ferry DR; Goll A; Rombusch M J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403 [TBL] [Abstract][Full Text] [Related]
12. Photolabile derivatives of 125I-apamin: defining the structural criteria required for labeling high and low molecular mass polypeptides associated with small conductance Ca(2+)-activated K+ channels. Wadsworth JD; Doorty KB; Ganellin CR; Strong PN Biochemistry; 1996 Jun; 35(24):7917-27. PubMed ID: 8672494 [TBL] [Abstract][Full Text] [Related]
13. Brownian dynamics simulations of the recognition of the scorpion toxin P05 with the small-conductance calcium-activated potassium channels. Cui M; Shen J; Briggs JM; Fu W; Wu J; Zhang Y; Luo X; Chi Z; Ji R; Jiang H; Chen K J Mol Biol; 2002 Apr; 318(2):417-28. PubMed ID: 12051848 [TBL] [Abstract][Full Text] [Related]
14. Isoform-specific inhibition of L-type calcium channels by dihydropyridines is independent of isoform-specific gating properties. Hu H; Marban E Mol Pharmacol; 1998 May; 53(5):902-7. PubMed ID: 9584217 [TBL] [Abstract][Full Text] [Related]
15. Two pathways for the activation of small-conductance potassium channels in neurons of substantia nigra pars reticulata. Yanovsky Y; Zhang W; Misgeld U Neuroscience; 2005; 136(4):1027-36. PubMed ID: 16203104 [TBL] [Abstract][Full Text] [Related]
16. Scyllatoxin, a blocker of Ca(2+)-activated K+ channels: structure-function relationships and brain localization of the binding sites. Auguste P; Hugues M; Mourre C; Moinier D; Tartar A; Lazdunski M Biochemistry; 1992 Jan; 31(3):648-54. PubMed ID: 1731919 [TBL] [Abstract][Full Text] [Related]
18. Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts. Schwinger RH; Hoischen S; Reuter H; Hullin R J Mol Cell Cardiol; 1999 Jan; 31(1):283-96. PubMed ID: 10072735 [TBL] [Abstract][Full Text] [Related]
19. Characterization and partial purification from pheochromocytoma cells of an endogenous equivalent of scyllatoxin, a scorpion toxin which blocks small conductance Ca(2+)-activated K+ channels. Auguste P; Hugues M; Borsotto M; Thibault J; Romey G; Coppola T; Lazdunski M Brain Res; 1992 Dec; 599(2):230-6. PubMed ID: 1337858 [TBL] [Abstract][Full Text] [Related]
20. Does small-conductance calcium-activated potassium channel contribute to cardiac repolarization? Nagy N; Szuts V; Horváth Z; Seprényi G; Farkas AS; Acsai K; Prorok J; Bitay M; Kun A; Pataricza J; Papp JG; Nánási PP; Varró A; Tóth A J Mol Cell Cardiol; 2009 Nov; 47(5):656-63. PubMed ID: 19632238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]